Feb 12, 2019 12:00 AM 1+ week ago
Insurance industry cost-control measures may be worsening the nation's opioid epidemic by limiting access to a key medication that treats addiction, according to a research letter published today in the Journal of the American Medical Association. Despite the medical profession's growing acceptance of the need for medications for addiction treatment that give hope to people suffering with opioid use disorder, a new study finds that insurance rules increasingly limited the use of buprenorphine among Medicare beneficiaries between 2007 and 2018....Read more.
**Content contained on this site is provided on an “as is” basis. 4Internet, LLC makes no commitments regarding the content and does not review it, so don't assume that it's been reviewed. What you see here may not be accurate and should not be relied upon. The content does not necessarily represent the views and opinions of 4Internet, LLC. You use this service and everything you see here at your own risk. Content displayed may be subject to copyright. Content is removed on a case by case basis. To request that content be removed, contact us using the following form: Contact Us.